Wearable technology refers to any sensor worn on the person, making continuous and remote monitoring available to many people with chronic disease, including multiple sclerosis (MS). Daily monitoring seems an ideal solution either as an outcome measure or as an adjunct to support rater-based monitoring in both clinical and research settings. There has been an increase in solutions that are available, yet there is little consensus on the most appropriate solution to use in either MS research or clinical practice. We completed a scoping review (using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews (PRISMA-ScR) guidelines) to summarise the wearable solutions available in MS, to identify those approaches that could potentially be utilised in clinical trials, by evaluating the following: scalability, cost, patient adaptability and accuracy. We identified 35 unique products that measure gait, cognition, upper limb function, activity, mood and fatigue, with most of these solutions being phone applications.

中文翻译：

---

用于测量多发性硬化症临床结果的可穿戴技术：范围界定审查

可穿戴技术是指佩戴在人身上的任何传感器，为许多患有慢性疾病（包括多发性硬化症）的人提供连续和远程监测。每日监测似乎是一种理想的解决方案，无论是作为结果衡量标准还是作为支持临床和研究环境中基于评估者的监测的辅助手段。可用的解决方案不断增加，但对于多发性硬化症研究或临床实践中最合适的解决方案几乎没有达成共识。我们完成了范围界定审查（使用系统评价的首选报告项目和范围界定荟萃分析扩展 (PRISMA-ScR) 指南）来总结 MS 中可用的可穿戴解决方案，以确定那些可能在临床试验中使用的方法，通过评估以下因素：可扩展性、成本、患者适应性和准确性。我们确定了 35 种独特的产品，用于测量步态、认知、上肢功能、活动、情绪和疲劳，其中大多数解决方案是手机应用程序。